This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
This election year, Capitol Hill buzzed with discussions about cannabis scheduling, hemp regulations, and the FDA’s evolving role in regulating cannabinoids. Yet, missing from these debates was one critical topic: the future of medical cannabis and protections for patients.
The delivery of precise doses of THC via an inhaler is associated with pain mitigation in patients with neuropathy and other complex pain conditions, according to clinical trial data published in the European Journal of Pain. Additional information regarding cannabinoids and pain appears online h ere.
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. New: This report is now available in Spanish and Japanese translations! See bottom of this article for downloads.
“The current study revealed the positive effects of MC [medical cannabis] therapy in some patients with FMS [ fibromyalgia syndrome] and resistance to conventional treatment. Thus, cannabinoids may be considered for FMS treatment.".
With everything happening in the news lately, we want to present some scientific data to help medical cannabis patients and adult-use consumers make informed decisions in regard to cannabis products available, product safety, and personal health.
This updated edition reviews over 450 peer-reviewed studies assessing the safety and efficacy of either whole-plant cannabis or cannabinoids for 23 different patient populations.
“In this study, we have demonstrated for the first time in a placebo-controlled trial that cannabinoid treatment has the potential to decrease disruptive behaviors associated with ASD, with acceptable tolerability.".
Project CBD , a California-based educational non-profit, has published an in-depth primer on Cannabinoid-Drug Interactions for health professionals, patients, and public policy-makers. The 33-page report, summarized below, is available for free download at the bottom of the page.
The CBD she took may or may not have helped, but according to a recent survey of tinnitus patients, she wasn’t alone in trying — or at least in being interested in cannabis as a potential remedy. But many more patients were willing to try, perhaps as an indication of the intractability of chronic tinnitus. And its conclusion?
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
Congress needs to hear from you about these priorities for patients: Pass the CJS Medical Cannabis Amendment without clawbacks to protect patients and providers.
.” The CDC’s interest in alternative methods of chronic pain management may be of particular significance to many medical cannabis patients. According to state-registry records, “Chronic pain is currently and historically the most common qualifying condition reported by medical cannabis patients (67.5
Americans for Safe Access (ASA) fully supports the regulation of cannabinoid products as part of our mission to ensure safe access for patients, and we want you to be successful in your efforts to do so in California. Unfortunately, our efforts to alter the legislation to protect these patients failed, and so did AB 2223.
“When it comes to addressing questions specific to the safety and therapeutic efficacy of cannabis, this publication provides the evidence that patients and their physicians – as well as lawmakers – need to know.”.
Patients require potent pain medication afterwards, often for extended periods. Some years ago, a woman named Jo Cameron had hip surgery but responded in a strange way: she reported a lack of […] The post Cannabinoids, pain, anxiety & fear: The biology of negative emotion appeared first on Leafly.
Historical sources show that people as early as 300 BCE were aware of cannabis’ appetite-stimulating effects —particularly for sweet and savory food—but who’d have thought that worms (that’s right, worms) also get a case of “the munchies” after being exposed to cannabinoids?
However, not many patients know the reasons behind how medical marijuana interacts with the body, so we prepared this comprehensive guide to use as a starting point for those considering cannabis treatment. Let’s go over the three main components of ECS to better understand, they are: endocannabinoids, cannabinoid receptors, and enzymes.
This article delves into the science behind medical marijuana, focusing on cannabinoids, the active compounds found in the cannabis plant, and their remarkable therapeutic effects. We’ll explore the diverse range of cannabinoids and their health benefits, providing insights into how these compounds are revolutionizing healthcare.
Trauma patients administered oral THC consume fewer opioids than do similarly matched controls, according to clinical trial data published in the journal Trauma Surgery & Acute Care. Sixty-six patients participated in the study. Half of the participants received dronabinol and the other half did not.
Published in Nature , the study found that just under a third of patients report significant improvements and over half report moderate improvements while using CBD -rich oil derived from cannabis (30% CBD , 1-2% THC ). Cannabinoid crystals.
In a newly published survey of 162 IBD patients in Puerto Rico, where medical cannabis is legal but recreational use is punishable with prison time , about 25% anonymously reported using cannabis to treat their symptoms. Findings from another recent survey of New York and Minnesota medical cannabis dispensary patients were similar.
For numerous medical marijuana patients throughout the United States with a medicinal marijuana program, it embodies a vital source of relief and healing. In this comprehensive guide, we’ll go over the importance of proper cannabis storage for patients who use medicinal marijuana as part of their treatment to manage symptoms.
As reported earlier , HB4161 focuses mainly on safety concerns, including permits, licensing, testing, taxes, and a new Hemp Social Equity Fund, but HB4161 also contains amendments that would affect registered Illinois medical cannabis patients and cottage hemp operators as well. Seeds may not be given or sold to any other person.”
As medical marijuana gains acceptance in mainstream medicine, patients and healthcare providers need to be well-informed about the various strains available and their unique effects on the body. United Patients Group specializes in providing reliable insights into the therapeutic use of medical marijuana and related plant medicine.
Terpenes interact with cannabinoids and are integral to what scientists call “the entourage effect” of whole plant medicine. This essentially means that the sum of the cannabis plant’s parts is greater than any individual cannabinoid (such as CBD or THC) or terpene. Healing with Marijuana Terpenes.
Dr. Goldstein has treated thousands of patients with medical cannabis. Goldstein will be leading the Medical Practicum at CannMed 2023 (May 15-17), where she will also be speaking about CBG and other minor cannabinoids during the main session. You have said that cannabigerol, or CBG, is one of your favorite cannabinoids.
Many of our patients have called in asking about cannabinoid hyperemesis syndrome ( CHS ), as this syndrome has been reported in the media numerous times over the past few months. This is a very rare syndrome that occurs in long-term heavy users of THC -rich cannabis. CHS was first reported in the medical literature in 2004.
My educational investment in the industry has offered me, through my focus on regulation and policy, the opportunity to collaborate as an advisor with several advocacy and education intermediary organizations focused on federal policy change for medical cannabis patients and a nascent, struggling industry that is supporting them.
Certain conditions require more cannabinoids than others. Price caps that could favor seriously ill patients/consumers will be an entirely new concept to the cannabis industry, but it’s no innovation. The reality is that cannabinoids have very individualized effects on human beings. Labels on products from the.
This resin is a sticky and thick-textured substance that contain a variety of terpenes and cannabinoid metabolites. The terpenes dictate how the particular strain of cannabis effects a patient. Schematic of terpene and cannabinoid biosynthesis in cannabis. Terpenes, in part, influence a cannabis strains’ flavor and aroma.
When unpleasant symptoms occur due to consuming large quantities of THC, it is referred to as Acute Cannabinoid Intoxication (ACI), and it can lead to people seeking emergency medical treatment. While cannabis has been shown to offer multiple therapeutic benefits, one drawback is its potential to induce anxiety and paranoia in some users.
Delaware cannabis patients and advocates will gather in Dover on Wednesday to rally support for The Delaware Patient Right to Grow Act, House Bill 243. This change would allow registered patients and registered caregivers to grow medical cannabis at home. Most patients respond best to specific strains of cannabis.
State lawmakers have approved a series of bills reducing penalties for marijuana possession offenses and strengthening and expanding legal protections for medical cannabis patients. Senate Bill 406 expands medical cannabis access and provides important new patient protections. The measures now await action from Democratic Gov.
Virginia has been one of the most reluctant states to consider marijuana law reform, though it recently began allowing some forms of cannabis oil for approved patients. And, 2019’s SB 1557 makes it possible for patients to get as much as 10mg of THC in each dose — the same limit as one serving size for edibles in adult-use states.
Science has proven that the benefits of cannabis impacts the quality of life of cancer patients in many ways. Research specifically looking at the impact of medical marijuana on the quality of life for cancer patients has shown positive outcomes. We noticed how these symptoms especially affect both physical health and patient morale.
Medicine in a Can A total of 15 patients with different incurable ailments would enroll in the Compassionate IND Program to study cannabis before it was officially shut down in 1992. When scientists blocked the CB1 cannabinoid receptor, ketamine did not prevent pain.
Benefits of Medical Marijuana for Pain Relief The medicinal properties of marijuana, particularly its cannabinoids, have been harnessed for centuries. These cannabinoids interact with the endocannabinoid system in the human body, modulating pain perception and inflammation. How Does Medical Cannabis Help Manage Chronic Pain?
The human body contains two main cannabinoid receptors, CB1 and CB2, both of which are abundant in the skin’s epidermal cells and sensory nerves. Cannabinoid receptors are also found in the skin’s mast cells, which are linked to inflammatory and allergic responses. So what do the cannabinoid receptors do?
The human body contains two main cannabinoid receptors, CB1 and CB2, both of which are abundant in the skin’s epidermal cells and sensory nerves. Cannabinoid receptors are also found in the skin’s mast cells, which are linked to inflammatory and allergic responses. So what do the cannabinoid receptors do?
Terpenes interact with cannabinoids and are integral to what scientists call “the entourage effect” of whole plant medicine. This essentially means that the sum of the cannabis plant's parts is greater than any individual cannabinoid (such as CBD or THC) or terpene.
In this article, we’ll closely examine this fascinating exploration of cutting-edge research and learn how this study could transform the future of pain relief for spinal cord injury patients. Persistent pain is a prevalent issue among SCI patients, with nearly 80% of affected individuals experiencing some degree of discomfort.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content